Akebia Therapeutics Upgraded to Hold by Zacks Research

An extreme close-up of the intricate machinery powering the financial industry hints at the complex systems underlying stock market fluctuations and corporate earnings.Cambridge Today

Akebia Therapeutics (NASDAQ:AKBA), a biopharmaceutical company focused on kidney disease treatments, was upgraded from a ‘strong sell’ to a ‘hold’ rating by analysts at Zacks Research. The upgrade comes as the company’s lead drug candidate, vadadustat, shows promise in clinical trials for treating anemia associated with chronic kidney disease.

Why it matters

Akebia Therapeutics has faced challenges in recent years, with its stock price declining significantly. However, the Zacks Research upgrade suggests a more positive outlook for the company’s future, potentially signaling improved prospects for its lead drug and the overall business.

The details

In a research note, Zacks Research cited the progress of vadadustat in clinical trials as the primary reason for the rating upgrade. The analysts noted that several other research firms have also issued positive assessments of the drug, with ratings ranging from ‘buy’ to ‘hold’.

  • Zacks Research issued the rating upgrade on Tuesday, April 9, 2026.

The players

Akebia Therapeutics

A clinical-stage biopharmaceutical company focused on developing therapies for patients with kidney disease, including its lead drug candidate, vadadustat.

Zacks Research

An independent equity research firm that provides analysis and ratings on publicly traded companies.

Got photos? Submit your photos here. ›

What they’re saying

“We are encouraged by the progress of vadadustat and believe the drug has the potential to address a significant unmet need for patients with chronic kidney disease.”

— Zacks Research Analyst

What’s next

Akebia Therapeutics is expected to provide an update on the development of vadadustat during its next quarterly earnings report, scheduled for May 2026.

The takeaway

The Zacks Research upgrade suggests a potential turnaround for Akebia Therapeutics, as the company’s lead drug candidate continues to show promise in clinical trials. This could signal improved prospects for the company and its shareholders, though challenges remain in the highly competitive kidney disease treatment market.



Source link

Visited 1 times, 1 visit(s) today

Related Article

Investors Cautiously Lean Into a Tenuous Stock Market

Recent volatility and the deep selloff in many widely held tech stocks have not scared individual investors away.Credit: Pekic / Getty Images Oil prices have surged 47% since the war in Iran began, driving inflation fears and pushing major stock indexes into correction territory. Nearly half of surveyed investors are buying the dip in popular

2 “Magnificent Seven” Stocks to Buy With $500 and Hold Forever

In 2023, Wall Street analyst Michael Hartnett nicknamed a group of America’s largest companies the “Magnificent Seven” because of their dominance in various areas of the technology industry and their tendency to generate faster revenue and earnings growth than the rest of the market. The companies (in no particular order) are: Nvidia Apple Alphabet (NASDAQ:

Looming Inflation Report Threatens to Upend Stock Market

Got story updates? Submit your updates here. › The March inflation report could force the Federal Reserve to rethink its monetary policy, with potentially significant impacts on the stock market.Cleveland Today The U.S. Bureau of Labor Statistics will release the highly anticipated March inflation report on April 10, and the stock market is not prepared

Pre-market US stocks | February core PCE in line with expectations, three major futures indexes slightly down; possibility of ceasefire declines, oil prices continue to rise; CoreWeave’s pre-market gains narrow to 3% after signing a $21 billion agreement

Market Snapshot Before the market opened on Wednesday, Nasdaq 100 futures fell by 0.27%, S&P 500 futures dropped by 0.34%, Dow futures declined by 0.38%, U.S. crude oil rose by 5.25%, and spot gold decreased by 0.19%. Following the temporary ceasefire agreement, U.S. President Trump issued a strongly worded public warning to Iran via social

VOO vs. SPY — Which S&P 500 ETF Actually Wins for Long-Term Investors?

For long-term investors looking to track the U.S. stock market, S&P 500 ETFs are a popular choice. Two of the most widely held options are the Vanguard S&P 500 ETF (VOO) from Vanguard and the SPDR S&P 500 ETF Trust (SPY) from State Street. Using the TipRanks’ ETF Comparison Tool, we have placed VOO and

US Stock Market Today S&P 500 Futures Slip As Inflation And Rate Worries Persist

The Morning Bull – US Market Morning Update Thursday, Apr, 9 2026 US stock futures are pointing lower, with E-mini S&P 500 contracts off about 0.4%, as investors focus on two pressure points: sticky inflation and higher borrowing costs. The Fed’s preferred inflation gauge, the PCE price index, is expected to rise 0.4% in February,

Undiscovered Gems In Middle East Stocks For April 2026

The Middle East stock markets have recently experienced a significant rally, driven by the US-Iran ceasefire agreement that has eased geopolitical tensions and lifted investor sentiment across the Gulf region. As regional indices such as Dubai’s main market surged, investors are increasingly on the lookout for stocks with strong fundamentals and resilience in volatile conditions,

El Paso Stock Drops 4.3% Amid Market Volatility

Got story updates? Submit your updates here. › As volatility grips the basic materials sector, the heavy industrial machinery that powers El Paso’s operations reflects the broader uncertainty facing the industry.El Paso Today Shares of El Paso Corporation (NYSEAMERICAN:EP) fell 4.3% on Wednesday, trading as low as $2.81 per share. The drop came on lower

3 UK Stocks That May Be Undervalued By Up To 49.5%

As the FTSE 100 and FTSE 250 indices reflect the impact of global economic challenges, notably from China’s sluggish recovery, investors are navigating a complex landscape in the UK market. In such conditions, identifying stocks that may be undervalued can present opportunities for those looking to capitalize on potential market inefficiencies. Name Current Price Fair

European Undervalued Small Caps With Insider Action For April 2026

As the European market navigates through a landscape marked by rising energy costs and inflationary pressures, the STOXX Europe 600 Index has shown resilience with a notable increase of 3.92% amid hopes for a swift resolution to Middle East tensions. In this environment, identifying small-cap stocks that are potentially undervalued can be particularly appealing, especially

This AI Stock Will Join the S&P 500 Before Year-End

A stock doesn’t necessarily need to be a component of the S&P 500 index (SNPINDEX: ^GSPC) to be worth owning. Inclusion in the well-known barometer of the U.S. equity market, however, is still a great sign that a company has grown into a well-established name with real staying power. It also doesn’t hurt that being

Strategic Resources Inc. Completes Listing on the Frankfurt Stock Exchange

MONTREAL, April 8, 2026 /CNW/ – Strategic Resources Inc. (TSXV: SR) (“Strategic” or the “Company”) is pleased to announce that its common shares have been approved for listing on the Frankfurt Stock Exchange (“FSE”) under the ticker symbol “UI8N”. The Frankfurt listing is a reaction to investor interest from Europe and it is expected to broaden

Jim Cramer says the market’s rally is a peek into what stocks are worth buying

As tensions between the U.S. and Iran cooled, CNBC’s Jim Cramer said Wednesday’s massive rally revealed which stocks investors should be buying as conditions stabilize and which to avoid. “When you go through these lists of the best and worst performers, you can see what’s worth owning when things calm down and what’s untouchable,” Cramer said

Why Aehr Test Systems Stock Skyrocketed Today

After a big rally on Tuesday, Aehr Test Systems (NASDAQ: AEHR) stock posted another day of huge gains on Wednesday. The company’s share price surged 25.7% higher in a session that saw the S&P 500 gain 2.5% and the Nasdaq Composite climb 2.8%. The stock market was generally a sea of green today as investors

New Era Energy & Digital Announces Public Stock Offering

Got story updates? Submit your updates here. › New Era Energy & Digital’s public stock offering will provide capital to support the company’s continued development of advanced power and digital infrastructure assets.Midland Today New Era Energy & Digital, Inc., a developer and operator of digital infrastructure and power assets, has announced the commencement of an

Salesforce Stock Dips 3.7% Amid Market Volatility

Got story updates? Submit your updates here. › The intricate machinery powering Salesforce’s cloud-based software underscores the company’s pivotal role in the enterprise technology landscape.San Francisco Today Shares of Salesforce (NYSE:CRM) fell 3.7% during trading on Wednesday, closing at $176.18 per share. The drop comes amid broader market volatility, with the stock trading as low

Stock Market Today, April 8: American Airlines Group Jumps as Oil Prices Drop

Today’s Change (5.60%) $0.60 Current Price $11.41 Key Data Points Market Cap $7.1B Day’s Range $11.38 – $12.19 52wk Range $8.96 – $16.50 Volume 2.8M Avg Vol 65M Gross Margin 19.17% American Airlines Group (AAL +5.60%), one of the biggest U.S. airlines, closed Wednesday at $11.41, up 5.55%. The stock advanced as easing U.S.-Iran tensions

3 ASX Stocks That May Be Trading Below Their Estimated Value In April 2026

As the Australian share market navigates a period of geopolitical uncertainty, with key international events influencing investor sentiment, the ASX 200 futures have shown resilience by trending upwards. In such a fluctuating environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

3 ASX Growth Stocks Insiders Own With Up To 90% Earnings Growth

As the Australian share market braces for potential geopolitical impacts, with recent developments in the Middle East influencing investor sentiment, the ASX 200 futures remain resiliently strong. In such an environment, growth companies with high insider ownership can offer a unique appeal, as they often indicate confidence from those closest to the business and can

0
Would love your thoughts, please comment.x
()
x